THERNEFRO THERAPET 75 G

Thernefro therapet 75 g is a product formulated for veterinary use intended for use on pets. The 75 g package contains a formulation designed to offer targeted support for the animal's general well-being, with particular attention to the functions that the product intends to support. The format is designed to guarantee practical administration and easy conservation, adaptable to different management habits.

The presentation and format in powder, gel or granules (as indicated on the label) make thernefro therapet 75 g suitable for direct administration or mixed with food, depending on the animal's preferences and the indications of the responsible veterinarian. The formulation is designed to integrate into the daily management of the animal, offering a complementary approach to standard veterinary therapies when necessary.

Thernefro therapet 75 g is designed to be easily dosed and to ensure satisfactory compliance even in animals who are selective in their food intake. The methods of use, warnings and contraindications must be carefully evaluated before use and followed according to the recommendations of veterinary personnel.

Therapeutic Indications

This section describes in detail the recommended areas of use for thernefro therapet 75 g, intended as nutritional and functional support for pets. The product is indicated as a complement to the diet to improve aspects related to general well-being, the support of physiological functions and the maintenance of nutritional balance in subjects who require specific attention.

It can be used to assist the management of conditions in which it is appropriate to provide selected nutrients useful for maintaining vitality, supporting the body's natural defenses and skin and digestive well-being, always as part of an overall strategy agreed with the veterinary doctor. Indications include support in periods of convalescence or increased metabolic demand, integrative support in elderly animals with particular nutritional needs and preventive use as a supplement to the diet to promote an optimal quality of life.

It is important to underline that thernefro therapet 75 g is not intended as a substitute for specific medical therapies but as a nutritional complement that can contribute to the improvement of parameters related to well-being; therefore use must take place after clinical evaluation, with prescription or advice from the veterinarian. Any change in the clinical picture during use of the product requires timely re-evaluation by the professional.

Composition

The composition of thernefro therapet 75 g has been designed to offer a balanced nutritional profile aimed at supporting the functions for which the product is proposed. The formulation includes a blend of essential nutrients, vitamins and minerals selected for their complementarity and their role in fundamental metabolic processes. Inside the product there are natural and/or synthetic active components designed to help maintain homeostasis, as well as excipients that guarantee stability, palatability and ease of administration.

The set of ingredients has been balanced to promote assimilation and minimize the risk of interference with the usual diet: proteins of selected origin, sources of rapidly or slowly absorbed carbohydrates depending on the formulation, essential fatty acids useful for skin health and cellular functions, and a vitamin and mineral matrix that contributes to the normal performance of organic functions.

The presence of functional substances, such as plant extracts or specific nutraceutical components, is calibrated in effective quantities to support nutritional objectives without exceeding. For reasons of safety and correct information, the detailed list of ingredients and their quantities is shown on the product label; Before use, it is advisable to read this information carefully and report any allergies to your vet.

Contraindications

Thernefro therapet 75 g must be used taking into account specific contraindications and precautions. It is not recommended for use in animals with proven hypersensitivity or known allergic reactions to any of the ingredients present in the formulation. In case of suspected allergy or previous episodes of food intolerance, use should be avoided until an accurate evaluation has been carried out by the veterinarian.

Furthermore, use in severely debilitated animals or with non-stabilised systemic pathologies requires a thorough clinical evaluation: supplementation may not be appropriate as a first therapeutic measure. Simultaneous administration with other supplements or drugs must be agreed with the veterinarian to avoid possible interactions or overdoses of nutrients.

In the presence of chronic diseases affecting excretory organs (such as the liver or kidneys), it is important that the use is decided exclusively by the veterinary surgeon. Finally, the product must not be administered as a replacement for a balanced diet or therapies prescribed for specific pathological conditions; lack of clinical response or worsening of the general state requires immediate suspension.

Safety of the drug for the species

The safety of thernefro therapet 75 g was considered within its intended use as a complementary product for pets. Each nutritional supplement must be evaluated in relation to the species, age, weight and physiological state of the subject. Administration must take place following the veterinarian's instructions to minimize the risk of adverse reactions.

In the absence of specific toxicity data reported in this sheet, it is essential to carefully observe the animal in the first phases of use: any symptoms such as vomiting, diarrhoea, lethargy, itching or skin reactions require immediate suspension of the product and veterinary consultation. Tolerability may vary between individuals; therefore, the introduction of the product into the diet can be gradual.

In subjects receiving pharmacological therapies at the same time, compatibility must be verified by the veterinarian. For general safety, store the product out of reach of children and other animals and respect the storage conditions. In case of accidental overdose, contact your veterinarian promptly.

Precautions

Before using thernefro therapet 75 g it is necessary to take a series of precautions. Always consult your veterinarian before starting supplementation, especially if the animal is on drug therapy, has chronic pathologies, is recovering, is pregnant or breastfeeding, or is under an age or weight for which the product may not be indicated.

Store the product in the original packaging, in a cool, dry place and out of the reach of children. Respect the handling instructions: avoid prolonged contact with the skin or oral mucosa and wash your hands after administration. Do not exceed the recommended dose without first consulting your veterinarian.

In the presence of suspicious clinical signs or worsening of the animal's condition, discontinue use and contact a professional promptly. Keep track of any adverse reactions and report them to your veterinarian. If the product is administered to multiple animals, check the individual compatibility of each subject.

Method of administration

Thernefro therapet 75 g is designed for practical and flexible administration. The form of presentation allows the product to be administered directly into the mouth or mixed with a small quantity of wet or dry food: to facilitate acceptance, it is recommended to mix the recommended dose with a small portion of the subject's favorite food.

The dosage must be established by the veterinarian based on the body weight, nutritional status, age and specific clinical needs of the animal; There are no standard numerical indications in this sheet to avoid inappropriate self-medication. If you forget to take a dose, do not double the next dose, but contact your vet.

If the product is mixed with food, administer the prepared portion immediately to ensure stability and palatability. To encourage compliance and monitor effectiveness, note the administrations and observe any changes in the general state of the animal.

Treatment program

The treatment program with thernefro therapet 75 g must be personalized according to the individual needs of the animal and the clinical evaluation carried out by the veterinarian. In general, integration can be envisaged as a short-term support cycle or as continuous administration at maintenance doses.

The duration of the program and the frequency of administration depend on specific objectives. Periodic clinical monitoring is recommended to evaluate the effectiveness of the treatment and verify the absence of adverse effects. For populations with special needs, such as elderly animals or those with chronic conditions, it is often useful to plan regular reassessments.

Finally, each program should include recommendations on any dietary modifications, laboratory checks or other complementary interventions deemed necessary by the veterinarian to optimize therapeutic and nutritional outcomes.

Target species

Thernefro therapet 75 g is intended for use in pets; the main target species is indicated on the product label. The use must be reserved for the species for which the product was formulated. Before administering the product to animals of species not explicitly indicated on the packaging, it is essential to consult a veterinarian.

For specific groups such as puppies, elderly animals, pregnant or lactating females, and subjects with particular clinical conditions, the adaptation of the dosage or the evaluation of alternatives must be carried out by the professional.